860 related articles for article (PubMed ID: 16881113)
21. Predictors of one year outcome in lupus nephritis: the importance of renal biopsy.
Esdaile JM; Federgreen W; Quintal H; Suissa S; Hayslett JP; Kashgarian M
Q J Med; 1991 Nov; 81(295):907-18. PubMed ID: 1808631
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH.
Gan HC; Hyoon K; Fong KY
Singapore Med J; 2002 Dec; 43(12):614-6. PubMed ID: 12693764
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
[TBL] [Abstract][Full Text] [Related]
24. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
26. The longterm prognosis of lupus nephritis: the impact of disease activity.
Goulet JR; MacKenzie T; Levinton C; Hayslett JP; Ciampi A; Esdaile JM
J Rheumatol; 1993 Jan; 20(1):59-65. PubMed ID: 8441167
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in diffuse proliferative lupus nephritis.
Abraham MA; Korula A; Jayakrishnan K; John GT; Thomas PP; Jacob CK
J Assoc Physicians India; 1999 Sep; 47(9):862-5. PubMed ID: 10778652
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.
Vu TV; Escalante A
J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368
[TBL] [Abstract][Full Text] [Related]
29. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.
Hiramatsu N; Kuroiwa T; Ikeuchi H; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y
Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590
[TBL] [Abstract][Full Text] [Related]
30. [Lupus nephritis: retrospective analysis of the course of the disease].
Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
[TBL] [Abstract][Full Text] [Related]
31. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.
Sisó A; Ramos-Casals M; Bové A; Brito-Zerón P; Soria N; Muñoz S; Testi A; Plaza J; Sentís J; Coca A
Lupus; 2008 Apr; 17(4):281-8. PubMed ID: 18413408
[TBL] [Abstract][Full Text] [Related]
32. The benefit of early treatment with immunosuppressive agents in lupus nephritis.
Esdaile JM; Joseph L; MacKenzie T; Kashgarian M; Hayslett JP
J Rheumatol; 1994 Nov; 21(11):2046-51. PubMed ID: 7869308
[TBL] [Abstract][Full Text] [Related]
33. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
34. Renal transplantation in lupus nephritis: a Brazilian cohort.
Oliveira CS; d Oliveira I; Bacchiega AB; Klumb EM; Albuquerque EM; Souza E; Suassuna JH; Ribeiro FM
Lupus; 2012 Apr; 21(5):570-4. PubMed ID: 22129601
[TBL] [Abstract][Full Text] [Related]
35. Severe paediatric systemic lupus erythematosus nephritis--a single-centre experience.
Hobbs DJ; Barletta GM; Rajpal JS; Rajpal MN; Weismantel DP; Birmingham JD; Bunchman TE
Nephrol Dial Transplant; 2010 Feb; 25(2):457-63. PubMed ID: 19755473
[TBL] [Abstract][Full Text] [Related]
36. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
Gunnarsson I; Sundelin B; Heimbürger M; Forslid J; van Vollenhoven R; Lundberg I; Jacobson SH
J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009
[TBL] [Abstract][Full Text] [Related]
37. [Long-term outcome of paediatric lupus nephritis].
Casado Picón R; Lumbreras Fernández J; Muley Alonso R; Vara Martín J
An Pediatr (Barc); 2010 May; 72(5):317-23. PubMed ID: 20392678
[TBL] [Abstract][Full Text] [Related]
38. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre.
Vachvanichsanong P; Dissaneewate P; McNeil E
Nephrol Dial Transplant; 2009 Sep; 24(9):2729-34. PubMed ID: 19395731
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.
Arriens C; Chen S; Karp DR; Saxena R; Sambandam K; Chakravarty E; James JA; Merrill JT
Clin Immunol; 2017 Dec; 185():3-9. PubMed ID: 27923701
[TBL] [Abstract][Full Text] [Related]
40. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
